Complement factor C7 contributes to lung immunopathology caused by mycobacterium tuberculosis

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Welsh, Kerry J ^a   Lewis, Cole T ^a   Boyd, Sydney ^a   Braun, Michael C ^b   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C7; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HISTOPATHOLOGY; LUNG; LYMPHOCYTE; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT C7; INTERFERON-GAMMA; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867027695     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/429675     Document Type: Article

References (36)

1. World Health Organization, Global tuberculosis control: epidemiology, strategy, financing. WHO Report 2009 2009 Geneva, Switzerland World Health Organization
2. Co D. O., Hogan L. H., Kim S. I., Sandor M., Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clinical Immunology 2004 113 2 130 136 2-s2.0-4644231177 10.1016/j.clim.2004.08.012 (Pubitemid 39296843)
3. Rao A., Avni O., Molecular aspects of T-cell differentiation. British Medical Bulletin 2000 56 4 969 984 2-s2.0-0034442057 10.1258/0007142001903634 (Pubitemid 32417163)
4. Actor J. K., Breij E., Wetsel R. A., Hoffmann H., Hunter R. L., Jagannath C., A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scandinavian Journal of Immunology 2001 53 5 464 474 2-s2.0-0035032920 10.1046/j.1365-3083.2001.00902.x (Pubitemid 32382270)
5. Jagannath C., Hoffmann H., Sepulveda E., Actor J. K., Wetsel R. A., Hunter R. L., Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scandinavian Journal of Immunology 2000 52 4 369 379 2-s2.0-0033834379 10.1046/j.1365-3083.2000.00770.x
6. Mashruwala M. A., Smith A. K., Lindsey D. R., Moczygemba M., Wetsel R. A., Klein J. R., Actor J. K., Jagannath C., A defect in the synthesis of interferon-gamma by the T cells of complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. Tuberculosis 2011 91 Supplement 1 S82 S89
7. Hollmann T. J., Mueller-Ortiz S. L., Braun M. C., Wetsel R. A., Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. Molecular Immunology 2008 45 7 1907 1915 2-s2.0-39149091052 10.1016/j.molimm.2007.10.037
8. Bohlson S. S., Strasser J. A., Bower J. J., Schorey J. S., Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3. Infection and Immunity 2001 69 12 7729 7735 2-s2.0-0035183110 10.1128/IAI.69.12.7729-7735.2001 (Pubitemid 33086603)
9. Borders C. W., Courtney A., Ronen K., Laborde-Lahoz M. P., Guidry T. V., Hwang S. A., Olsen M., Hunter R. L., Hollmann T. J., Wetsel R. A., Actor J. K., Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6′-dimycolate. Scandinavian Journal of Immunology 2005 62 2 123 130 2-s2.0-23844444138 10.1111/j.1365-3083. 2005.01643.x (Pubitemid 41176494)
10. Hwang S. A., Welsh K. J., Boyd S., Kruzel M. L., Actor J. K., Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen. Tuberculosis (Edinb) 2011 91 supplement 1 S90 S95 10.1016/j.tube.2011.10.017
11. Welsh K. J., Hwang S. A., Hunter R. L., Kruzel M. L., Actor J. K., Lactoferrin modulation of mycobacterial cord factor trehalose 6-6′-dimycolate induced granulomatous response. Translational Research 2010 156 4 207 215 2-s2.0-77957303723 10.1016/j.trsl.2010.06.001
12. Welsh K. J., Abbott A. N., Hwang S. A., Indrigo J., Armitige L. Y., Blackburn M. R., Hunter R. L., Actor J. K., A role for tumour necrosis factor- α complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6′-dimycolate induced granulomatous response. Microbiology 2008 154 6 1813 1824 2-s2.0-48449094384 10.1099/mic.0.2008/016923-0
13. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
14. Indrigo J., Hunter R. L., Actor J. K., Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 2002 148 7 1991 1998 2-s2.0-0036062018 (Pubitemid 34785283)
15. Kuijpers T. W., Nguyen M., Hopman C. T. P., Nieuwenhuys E., Dewald G., Lankester A. C., Roos A., van der Ende A., Fijen C., de Boer M., Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease. Molecular Immunology 2010 47 4 671 677 2-s2.0-73149121899 10.1016/j.molimm.2009.10.017
16. Carroll M. V., Lack N., Sim E., Krarup A., Sim R. B., Multiple routes of complement activation by Mycobacterium bovis BCG. Molecular Immunology 2009 46 16 3367 3378 2-s2.0-70349595391 10.1016/j.molimm.2009.07.015
17. Schlesinger L. S., Bellinger-Kawahara C. G., Payne N. R., Horwitz M. A., Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. Journal of Immunology 1990 144 7 2771 2780 2-s2.0-0025216480 (Pubitemid 20136689)
18. Hetland G., Johnson E., Aasebo U., Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scandinavian Journal of Immunology 1986 24 5 603 608 2-s2.0-0022976676 (Pubitemid 17189281)
19. Reis E. S., Barbuto J. A. M., Isaac L., Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. Immunobiology 2007 212 3 151 157 2-s2.0-33947723809 10.1016/j.imbio.2006.11.010 (Pubitemid 46505955)
20. Kemper C., Atkinson J. P., T-cell regulation: with complements from innate immunity. Nature Reviews Immunology 2007 7 1 9 18 2-s2.0-33845905781 10.1038/nri1994 (Pubitemid 46020823)
21. Drouin S. M., Corry D. B., Kildsgaard J., Wetsel R. A., Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. Journal of Immunology 2001 167 8 4141 4145 2-s2.0-0035887610 (Pubitemid 32954285)
22. Drouin S. M., Corry D. B., Hollman T. J., Kildsgaard J., Wetsel R. A., Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. Journal of Immunology 2002 169 10 5926 5933 2-s2.0-0037111427 (Pubitemid 35291699)
23. Hawlisch H., Wills-Karp M., Karp C. L., Köhl J., The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Molecular Immunology 2004 41 2-3 123 131 2-s2.0-2442678025 10.1016/j.molimm.2004.03.019 (Pubitemid 38668621)
24. Chen A., Gaddipati S., Hong Y., Volkman D. J., Peerschke E. I. B., Ghebrehiwet B., Human T cells express specific binding sites for C1q: role in T cell activation and proliferation. Journal of Immunology 1994 153 4 1430 1440 2-s2.0-0028141374 (Pubitemid 24251088)
25. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M. F., Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nature Medicine 2002 8 4 373 378 2-s2.0-0036104834 10.1038/nm0402-373 (Pubitemid 34407032)
26. Suresh M., Molina H., Salvato M. S., Mastellos D., Lambris J. D., Sandor M., Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. Journal of Immunology 2003 170 2 788 794 2-s2.0-0037438634 (Pubitemid 36070530)
27. Verschoor A., Brockman M. A., Gadjeva M., Knipe D. M., Carroll M. C., Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. Journal of Immunology 2003 171 10 5363 5371 2-s2.0-0242494429 (Pubitemid 37432822)
28. Korty P. E., Brando C., Shevach E. M., CD59 functions as a signal-transducing molecule for human T cell activation. Journal of Immunology 1991 146 12 4092 4098 2-s2.0-0026079656
29. Longhi M. P., Sivasankar B., Omidvar N., Morgan B. P., Gallimore A., Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. Journal of Immunology 2005 175 11 7098 7102 2-s2.0-28244470817 (Pubitemid 41713401)
30. Mittrücker H. W., Steinhoff U., Köhler A., Krause M., Lazar D., Mex P., Miekley D., Kaufmann S. H. E., Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2007 104 30 12434 12439 2-s2.0-34547624348 10.1073/pnas.0703510104 (Pubitemid 47206155)
31. Paige C., Bishai W. R., Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Cellular Microbiology 2010 12 3 301 309 2-s2.0-77950616102 10.1111/j.1462-5822.2009.01424.x
32. Churchyard G. J., Kaplan G., Fallows D., Wallis R. S., Onyebujoh P., Rook G. A., Advances in immunotherapy for tuberculosis treatment. Clinics in Chest Medicine 2009 30 4 769 782 2-s2.0-71849100552 10.1016/j.ccm.2009.08.009
33. Wayne L. G., Sohaskey C. D., Nonreplicating persistence of Mycobacterium tuberculosis. Annual Review of Microbiology 2001 55 139 163 2-s2.0-0034780485 10.1146/annurev.micro.55.1.139 (Pubitemid 32978103)
34. Roy E., Lowrie D. B., Jolles S. R., Current strategies in TB immunotherapy. Current Molecular Medicine 2007 7 4 373 386 2-s2.0-34250890771 10.2174/156652407780831557 (Pubitemid 46979701)
35. Mayanja-Kizza H., Jones-Lopez E., Okwera A., Wallis R. S., Ellner J. J., Mugerwa R. D., Whalen C. C., Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. Journal of Infectious Diseases 2005 191 6 856 865 2-s2.0-14844285340 10.1086/427995 (Pubitemid 40349799)
36. Wallis R. S., Kyambadde P., Johnson J. L., Horter L., Kittle R., Pohle M., Ducar C., Millard M., Mayanja-Kizza H., Whalen C., Okwera A., A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS 2004 18 2 257 264 2-s2.0-10744233930 10.1097/00002030-200401230-00015 (Pubitemid 38253448)